Navigation Links
Mouse Model of Age-Related Macular Degeneration Developed
Date:1/28/2008

Researchers say it will allow for testing of new drugs for vision-robbing disease

MONDAY, Jan. 28 (HealthDay News) -- The first animal model of age-related macular degeneration (AMD) has been developed by Cleveland Clinic researchers.

This mouse model will help improve knowledge about the development and progression of the disease and will enable pre-clinical testing of new drugs for AMD, a leading cause of blindness in the elderly.

The researchers created this animal model of AMD by modifying specific proteins found in mouse blood, forcing the immune system to mount a response that led to the development of the characteristics of AMD.

"More than 8 million Americans are living with vision loss caused by AMD, and 250,000 new cases are diagnosed each year," research team leader Joe G. Hollyfield, of Cleveland Clinic's Cole Eye Institute, said in a prepared statement.

"The discovery of the animal model of AMD presents a significant opportunity to efficiently and effectively develop and test novel therapies to both prevent the disease and slow vision loss. Research conducted today may one day help find a cure for this progressive disease," Hollyfield said.

The creation of the mouse AMD model is described in a report in the Jan. 27 online edition of Nature Medicine.

AMD is the most common cause of vision loss among American adults aged 60 and older. The disease gradually destroys sharp, central vision, which is needed for seeing objects clearly and for common daily tasks such as reading and driving.

More information

The U.S. National Eye Institute has more about age-related macular degeneration.



-- Robert Preidt



SOURCE: Cleveland Clinic, news release, Jan. 27, 2008
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
2. Mouse vision has a rhythm all its own
3. Mouse Study Gives Clues to Colitis
4. Mouse mammary tumor virus can replicate in human cells
5. A longer-living, healthier mouse that could hold clues to human aging
6. Gene Tweak Reverses Aging in Mouse Skin Cells
7. Chromatin remodeling complex connected to DNA damage control
8. Health care incentive model offers collaborative approach
9. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
10. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
11. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mouse Model of Age-Related Macular Degeneration Developed
Mouse Model of Age-Related Macular Degeneration Developed
(Date:1/8/2009)... 8 Bladder cancer is mu...Americans, but the reasons long believed to explai...erences for such patients compared to their white ...hed in the Jan. 1 issue of the journal Cancer . ,...tors and patients: If age, tumor type, and stage o...
(Date:1/8/2009)...esota receives $20,000 to support local programs a... , , MINNEAPOLIS, Minn., Jan. 8 /PRNewswire-USN...received $20,000 in funding to support Project UNI... national program. Project UNIFY is an initiative ...in an effort to promote school communities where a...
(Date:1/8/2009)...iversity of Granada and the University of Barcelon...triterpenoid compound isolated from olive-skin pom...roliferation and causes apoptotic death in colon-c...ound and it is able to induce apoptosis or program... intrinsic mitochondrial pathway. Scientifics sugg...
(Date:1/8/2009)...nd a new nasal spray vaccine to provide complete p...g to a study published today in the Nature journal...rium, Clostridium botulinum , which produces toxi...scles that control breathing fail. Out of an avera...ant botulism (infants, intestines, unlike adults, ...
Breaking Medicine News(10 mins):Health News:Why Bladder Cancer Is Deadlier for Some 2Health News:Why Bladder Cancer Is Deadlier for Some 3Health News:Why Bladder Cancer Is Deadlier for Some 4Health News:Special Olympics Minnesota Launches Project UNIFY to Energize Youth 2Health News:Nose-spray vaccine against botulism effective in first tests 2Health News:Nose-spray vaccine against botulism effective in first tests 3Health News:Nose-spray vaccine against botulism effective in first tests 4
... researchers have developed a faster, less expensi...retches of DNA. Genes account for only 2.5 percent...ses can result not only from mutant genes, but fro...genes. Diseases are known to occur as a consequen...
...und that waiting just two minutes to cut the umbil...ant' health boost as it reduces the risk of blood ... McMaster University in Hamilton, Canada, and invo...author Eileen Hutton, assistant dean of midwifery ...
...anned food items, are most popular in the West. Bu...mful to children.Pure is a general term for food,...ound, pressed, and/or strained to the consistency ...id. The term comes from French, where it meant pu...
...tion is becoming increasingly popular.More than th... Assisted Reproductive Technologies (ART) IVF , o...n Britain, ART accounts for 1.4 per cent of all bi...while many more women undergo treatment unsuccessf...
Other Medicine News:Health News:Genome Annotation by Mutation 2Health News:Genome Annotation by Mutation 3Health News:Genome Annotation by Mutation 4Health News:Genome Annotation by Mutation 5Health News:2 Minute Delay in Cutting Cord can Give Babies a 'significant' Health Boost 2Health News:Pureed Products Unnecessary and Harmful for Babies UK Expert 2Health News:Questions Raised Over Safety of In-vitro Fertilization 2Health News:Questions Raised Over Safety of In-vitro Fertilization 3Health News:Questions Raised Over Safety of In-vitro Fertilization 4
(Date:1/8/2009)..., Patients treated at the initial dose in an ongo... viral load decline after three days , , Confer...an. 8 Anadys Pharmaceuti...ts from the first cohort of an ongoing Phase Ib cl...nal non-nucleoside polymerase inhibitor. ANA598 w...
(Date:1/7/2009)..., First of Several Products in Development Based ...gy to Stimulate Natural BioRegeneration; FDA Filin...OWN, N.J., Jan. 7 Oste...rging field of biologic products for regenerative ...ivotal clinical trial for its DuraTech(TM) BioRege...
(Date:1/6/2009)..., COMMACK, N.Y., Jan. 6 In recent...er, University of Memphis , scientists found that...rn(R), is the first and only proven ingredient to ...thereby increasing blood nitrate/nitrate (NOx) in ...dilator and enables an increase in blood flow to t...
(Date:1/6/2009)..., PARIS, France, January 6 /PRNewswire-FirstC...to Extend the Collaboration Until,December 2011 ,...ion to Include Antibody,Discovery in Ophthalmolog... to ExonHit if Allergan,Sublicenses to a Third Pa...EHT) today announced a reinforcement,of its exist...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add on Therapy Studies 2351 1Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add on Therapy Studies 2351 2Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add on Therapy Studies 2351 3Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add on Therapy Studies 2351 4Study Shows Lantus 28R 29 Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control 2347 1Study Shows Lantus 28R 29 Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control 2347 2Study Shows Lantus 28R 29 Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control 2347 3Study Shows Lantus 28R 29 Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control 2347 4Gum Care Helps Control Type 2 Diabetes and Its Complications 21254 1Gum Care Helps Control Type 2 Diabetes and Its Complications 21254 2Gum Care Helps Control Type 2 Diabetes and Its Complications 21254 3Leiner Health Products Issues Allergy Alert on Undeclared Allergens in Liquimax 28R 29 Multivitamin 21251 1Leiner Health Products Issues Allergy Alert on Undeclared Allergens in Liquimax 28R 29 Multivitamin 21251 2
Millar Mikro-Tip pressure intravascular catheters provide a simple, efficient and highly accurate method of measuring pressures in the heart or cardiovascular system. These reusable, thromboresistant
These dual pressure sensor catheters incorporate a lumen for sampling/slow-speed injection, slow-speed injection/guide wire, or high-speed injection/guide wire. The model SPC-784A for high-speed inje
...ikro-Tip Pressure Catheters; Millar manufactures a...s for simultaneous high fidelity pressure measurem...ressure gradients across a valve, between chambers... made of Polyurethane material (some include a wov...
... the United States dying from Sudden Cardiac Death...d that AEDs be used as a standard of care in the t...g shock during a cardiac arrest, but the CardioViv...during and after resuscitation. Plus this compact ...
Medicine Products: